|
| Hackathon: Tech & Media Solutions to Reduce STIs | The National Academies, in collaboration with the Centers for Disease Control and Prevention and National Association of County and City Health Officials, will host a hackathon to generate innovative solutions to address the increase in cases of sexually transmitted infections (STIs) in the United States. Competing teams will consider how technologies can be leveraged to promote sexual health as they focus on creating new solutions to address the STI epidemic. Winning teams will receive cash prizes, mentorship and a publication opportunity. First and second place Hackathon winners in each track will be eligible to receive a grant from the National Academies to continue work to develop their proposed solution. - Each first place Hackathon winning team: $20,000 grant.
- Each second place Hackathon winning team: $5,000 grant.
- In addition, two $5,000 YouTube Health Innovation Prizes will be awarded.
- All winning teams will have the opportunity to contribute to "NAM (National Academy of Medicine) Perspectives," a health periodical that provides a venue for leading health, medical, science and policy experts.
June 22–23, 2023
Location: Beckman Center in Irvine, Calif.
|
|
| School of Medicine Office of Research Informational Webinar: Creating a Compelling and Compliant NIH Biosketch | The Research Development Unit will lead a presentation on how to create and update your NIH biosketch, as well as how to edit your biosketch to be responsive to the grant application. This webinar is open to graduate students, post-docs and faculty members.
Tuesday, June 27, noon to 1 p.m. |
|
| Announcing the Clinical Trial Investigator Certificate Program | The UCI Alpha Clinic, the Stem Cell Research Center and the School of Medicine Dean’s Office of Research (SOM OR) are pleased to announce the UCI Alpha Clinic Clinical Trial Investigator Certificate Program (Stem Cell Clinical Professional Training Program – SCCPTP), a new clinical trial investigator certificate program that will open for enrollment in September 2023.
This training program aims to address the existing gaps in the delivery of transformative cell and gene therapies by educating the next generation of physicians, advanced practice providers and pharmacists in clinical trial scientific methodology with a focus on novel treatment modalities.
The program will be delivered in a hybrid format with afternoon Zoom sessions to accommodate working professionals. There will also be 10 in-person clinical research observational sessions (inpatient and outpatient clinical trial units) that will take place during work hours (8 a.m. to 4 p.m.).
Eligibility: - Completed their professional degrees (i.e., MD, NP, PA and PharmD).
- Limited previous exposure to clinical research.
- Demonstrated interest in being involved in clinical trials, with a special focus on cell and gene therapies.
- Ability to attend the in-person clinical observation sessions.
Application Process:
- Letter of interest (one page): Briefly describe your interest in participating and the area of clinical practice and populations you can enroll in cell and gene therapy trials.
- Letter of support from the Department Chair or Division Chief.
- CV or NIH biosketch.
Applications will be reviewed by a clinical trialist committee, and the program will be launched in fall 2023. Please apply by July 3, 2023. Send all materials and direct any questions to Yuna Muyshondt, assistant director at UCI Alpha Clinic (chuny@hs.uci.edu).
Deadline: Monday, July 3, 2023 |
|
| Second Call for New Proposals: Basic and Translational Research Programs Requiring Wet Lab Space | There is a second call for new proposals for basic and translational research programs requiring wet lab space. This is a follow-up call to the original RFP in 2021. This call is for new proposals.
Please submit your proposals for research programs to Shauna Stark, starks@hs.uci.edu by Sept. 1, 2023. The School of Medicine’s Office of the Dean will reach out to you with recommendations for revision so they can be forwarded to the Office of the Vice Chancellor for Health Affairs by Oct. 15, 2023.
Deadline: Friday, Sept. 1, 2023 |
|
| Join AAAS for Future Honorary Fellow Eligibility | Researchers are encouraged to become members of AAAS (American Association for the Advancement of Science). There are many member benefits and membership in this esteemed organization has been a time-honored tradition in the scientific community.
An important benefit of membership in AAAS is to position yourself to be elected as an AAAS Honorary Fellow. AAAS Fellows are a distinguished group of scientists, engineers and innovators who have been recognized for their extraordinary achievements. In a tradition stretching back to 1874, Fellows are elected annually by the AAAS Council. View the list of AAAS Fellows elected in 2022.
The UCI School of Medicine Awards Nominations Committee would like to nominate our researchers for consideration for election to AAAS Fellowship. One must be a continuous member of AAAS for the four-year period leading up to the year of nomination. Please make yourself eligible for this honor and become a member. |
|
| Have You Received a New Award? | | Have you or someone on your research team received a new grant, i.e., research funding? The School of Medicine Office of Research would like to know! Please fill out this short New Funding/Grant Survey form. |
|
| Funding Opportunities Recently Added to Calendar |
| Chan Zuckerberg Initiative (CZI): Collaborative Pairs Pilot Project Awards in Neurodegeneration and Neuroscience | The Chan Zuckerberg Initiative (CZI) invites letters of intent for the Collaborative Pairs Pilot Project Awards to support pairs of investigators and their teams to explore innovative, interdisciplinary approaches to address critical challenges in the neurodegenerative disease field and in areas of fundamental neuroscience such as the cellular, molecular and circuit mechanisms of cognition & memory and the neuroscience of sleep.
Awards are $200,000 in total costs per collaborating pair for a period of 18 months, after which successful projects will be eligible to apply for additional four-year acceleration grants that build on pilot phase studies. Collaborative Pairs teams will benefit from the support, mentoring and collaborative interactions of the CZI Neurodegeneration Challenge Network, as well as interactions with the broader CZ Science programs and grantee network.
Eligibility: Pairs from different institutions strongly encouraged; must not have received any funding previously to work together. At least one member of the pair must be early career (hired after June 22, 2017) or mid career (hired between June 22, 2013 and June 22, 2017).
Letter of Intents Deadline: Thursday, June 22, 2023, by 5 p.m. PT |
|
| ARPA-H launches its first research program: Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) | NITRO aims to address current issues surrounding osteoarthritis treatment by developing new ways of helping the human body repair its own joints. In particular, the program focuses on three technical areas: injectable bone regeneratives, injectable cartilage regeneratives, and replacement joints built from human cells.
To meet these goals, ARPA-H invites those interested in NITRO to read the full BAA and email ARPA-H about joining the program. Successful applicants will work with a diverse team of performers to address the biggest challenges facing osteoarthritis patients today. In doing so, NITRO performers may help reduce health costs, increase access, and drastically improve the lives of millions of people with or at risk for osteoarthritis. Based on evaluation of the abstract, ARPA-H may request a full proposal from BAA respondents.
Abstract Deadline: Friday, June 23, 2023, by 2 p.m. |
|
| NSF BioFoundries to Enable Access to Infrastructure and Resources for Advancing Modern Biology and Biotechnology | BioFoundries is an infrastructure program from the National Science Foundation (NSF) that is designed to accelerate advances in the biological sciences, chemical biology, biotechnology and bioengineering, via access to modern infrastructure, technology and capacity. Each BioFoundry should enclose a scientific ecosystem that includes in-house research scientists across all relevant disciplines supported by NSF, technical staff including cyberinfrastructure experts, external users and other contributors who collectively form a community of practitioners who share tools, reagents, workflows, software, samples and data.
Knowledge sharing should be a central tenet, designed to strengthen collaborations among researchers and enable them to work in new ways and to foster new modalities of research and education/training, for the purpose of accelerating discovery and advancing development. BioFoundries should also promote new avenues for translating such knowledge and technology broadly in ways that benefit society.
Awards totaling $15 million to $24 million over a six-year period are anticipated. UCI may submit only one proposal in response to this call. Therefore, interested applicants are asked to submit a preliminary application via the UCI Review system.
Deadline: Monday, June 26, 2023 |
|
| Call for Proposals: 2024 NIH Director's Early Independence Award | The NIH Director's Early Independence Award supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career.
For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations, are strongly encouraged to apply to this Funding Opportunity Announcement.
In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director's Early Independence Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.
UCI may submit no more than two applications to this competition. Therefore, interested applicants are asked to submit a preliminary application to the Office of Research via the UCI Review application system.
Abstract Deadline: Thursday, June 29, 2023 |
|
| 2024 Searle Scholars Program | UCI has the opportunity to nominate two candidates for the 2024 Searle Scholars Program, which recognizes outstanding new faculty with the potential to make innovative and high-impact contributions to research in biochemistry, cell biology, genetics, immunology, neuroscience, pharmacology, and related areas in chemistry, medicine and the biological sciences.
The Searle Scholars Program does not ordinarily support purely clinical research, but has supported research programs that include both clinical and basic components. Potential applicants who are unsure if their research is appropriate for this program are encouraged to examine the research interests of present and former Searle Scholars on their website and/or consult with UCI Corporate & Foundation Relations staff.
Eligibility: The candidate’s first appointment to an Assistant Professor, tenure-track position must have begun on or after May 1, 2022.
Interested applicants are asked to submit a preliminary application to the Office of Research via UCI Review.
Deadline: Monday, July 10, 2023 |
|
| UC Noyce Initiative 2023 Call for Applications | The UC Noyce Initiative is a partnership between five University of California campuses (Berkeley, Davis, Irvine, San Francisco, Santa Barbara) that honors the legacy of Ann S. Bowers and Robert N. Noyce by advancing computing, information science and engineering for the benefit of society. To further this aim, the UC Noyce Initiative intends to support research efforts that are innovative, have the potential for high-impact, and hold a strong promise for follow-on funding. The UC Noyce Initiative is particularly interested in supporting high-risk, high-reward research that typically does not qualify for traditional or federal funding agencies. In 2023, the UC Noyce Initiative requests proposals in two thematic focus areas: (1) Computational Health; (2) Privacy and Security.
Researchers may apply for either a Multi-Campus Partnership Award (up to $1M over 2 years) or a Single Campus Award (up to $300K over 2 years). The initiative anticipates awarding up to four Multi-Campus Partnership Awards and up to 10 Single Campus Awards in 2023.
The UC Noyce Initiative will hold a one-hour informational webinar on June 27. For more information, please view/download the full RFP.
Tuesday, June 27, 2023, 12 p.m.
Meeting ID: 955 0850 8861
Deadline: Tuesday, Aug. 15, 2023, at 6 p.m. |
|
| NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) (PAR-23-198) | The NIAID New Innovators Award supports postdoctoral and other candidates in non-independent positions or newly independent Early Stage Investigators of exceptional creativity who propose novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research of priority to NIAID. Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged. Applications from individuals with diverse backgrounds and in any topic relevant to the mission of NIAID are welcome. View the NOFO.
Next Available Due Date: Friday, Oct. 13, 2023
Expiration Date: Oct. 11, 2025 |
|
| Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) (RFA-HG-23-017) | The purpose of this initiative is to support investigator-initiated research in genomics and health equity, with the ultimate goal of developing approaches, generating and disseminating data, and implementing metrics or interventions that will advance the equitable use of genomics to improve health in U.S. populations. Awardees will conduct innovative and generalizable research in genomics and health equity spanning across genomic research areas and will incorporate a plan for enhancing diverse perspectives. Applications supporting New or Early Stage Investigators from diverse backgrounds, including those from groups traditionally underrepresented in the biomedical, behavioral, and clinical research workforce, as described in the NIH Notice of Interest in Diversity (NOT-OD-20-031), are encouraged.
This Notice of Funding Opportunity (NOFO) requires a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Applications without a PEDP will not be reviewed. View the NOFO.
Next Available Due Date: Wednesday, Nov. 8, 2023
Expiration Date: July 9, 2025 |
|
| For More Funding Opportunities | For more funding opportunities and resources for your funding search, visit the Funding Opportunities page on the new and updated website for the UCI School of Medicine.
For a curated, searchable and filterable list of funding opportunities by NIH in their weekly NIH guide listserv, check out the School of Medicine Funding Search Tool. |
|
| Upcoming Seminars & Events |
| Research!America's Science and Technology Career Summit | This summit for early career researchers will feature a series of events designed to engage and equip them with tools for success. The sessions will provide early career researchers with the opportunity to explore an array of career paths, network with fellow researchers, participate in professional development workshops, and engage in meaningful discussions around issues critical to the success of the R&D ecosystem. Upcoming sessions: - Session 4: Building a Strong Resume: A Hiring Manager’s Perspective
Date: Wednesday, June 21, 2023, 9:30 to 11 a.m. - Session 5: Science and Startups: Taking your Research to the Next Level
Date: Wednesday, June 28, 2023, 9:30 to 10:45 a.m.
|
|
| UCLA CTSI K/CDA Grant Writing Virtual Workshop | The UCLA Clinical and Translational Science Institute (CTSI) will be holding a workshop for junior investigators who have applied, are applying, or thinking about applying for a NIH K/Career Development Award. Topics to be covered: Navigating the NIH K Award Process; Choosing Your Mentorship Team; Writing the NIH K Award; How Reviewers Evaluate K Awards; Common Critiques from NIH K Study Sections; Considerations in Applying for a K99 Award: the NIH "Pathway to Independence." View the detailed agenda View the detailed agenda here. Register by June 21 at 5 p.m.
Thursday, June 22, 8 a.m. to noon |
|
| NCI Drug Development Workshop II: Specialized Topics in Preclinical Development of Small Molecule Cancer Drugs | This workshop will encompass a series of six webinar-based lectures. They will address specialized topics that are important for the preclinical development of small molecule cancer drugs. The intention is to help investigators mitigate the translational risk of selected candidates during their later stages of product development and increase the chances of entering clinical evaluation. The intended audience is translational scientists who are interested in preclinical development of cancer drugs. Junior faculty, staff and trainees are encouraged to attend this workshop. Sessions start at 10 a.m. PT, and includes 60–90 minutes of lectures and 15 minutes of facilitated discussion. View the agenda for more information about this workshop.
June 22 to July 28, 2023, on selected Thursdays and Fridays, at 10 a.m. PT |
|
| Center for Aging Research in Down Syndrome Seminar Series | Down syndrome Induced Neurodevelopmental Senescence, by Hiruy Meharena, PhD, assistant professor in the Departments of Neurobiology and Molecular Biology in the School of Biological Sciences at UC San Diego.
Hiruy’s group focuses on understanding how the brain develops at the molecular and cellular level to accomplish cognitive tasks. The overarching goal is to establish a comprehensive molecular map of the developing human brain in order to identify the cell-type specific gene-networks driving neurodevelopmental disorders associated with intellectual disability, including Autism Spectrum Disorder and Down syndrome.
Friday, June 30, 11 a.m. PT
|
|
| 2023 Science Policy and Advocacy Certificate Program | The 2023 Science Policy and Advocacy Certificate Program is a virtual program from UCI’s GPS-STEM in collaboration with several partners including the Journal of Science Policy & Governance (JSPG) as a founding partner. The program is designed to teach STEM PhDs and postdoctoral trainees the essential skills required for a career in science policy. The program covers a range of topics including policy development, communication, resources and funding opportunities, networking and career pathways.
Register by June 23 to be considered for the program. Registration is not limited to UCI trainees. For questions, please contact Joanne Ly, joannl6@hs.uci.edu.
July 11 to Sept. 19, every Tuesday, 3 to 4:30 p.m. PT |
|
| UCI Conte Center Seminar Series | |
Reinforcement Learning, Monoamines and the effort to connect neurochemical dynamics to Human Perception, by Read Montague, PhD, Virginia Tech Carilion Vernon Mountcastle Research Professor; Director, Center for Human Neuroscience Research; Franlin Biomedical Research Institute, Virginia Tech. Tuesday, July 11, 4 to 5 p.m. PT
Location: Hybrid event at Plumwood House (across from Medical Education) and via Zoom
|
|
| Statistics Workshops, presented by Insight Research Services Associated | Insight Research Services Associated, an Australia-based company, is presenting workshops online May through July at a time suitable for participants in North America. The workshop in July will cover an Introduction to Structural Equation Modelling.
There is a registration fee. These workshops are aimed at non-statisticians as well as statisticians new to these fields. For questions, contact Mark at m.griffin@insightrsa.com. Keep up to date with the training programs we deliver by joining our email list. Register and learn more about our workshops.
July 17-20, 1 to 4 p.m. PT
|
|
| CHOC Research Education: NIH Grant Writing: Funding Success Part 2 | Speakers: Sheila Cherry, PhD, and Jessica Lerch, PhD
Topics: - How to tailor your proposals to grant reviewers
- How to position your research and yourself to make reviewers your research advocates
Wednesday, July 19, noon to 1:15 p.m.
|
|
| NIH All About Grants Podcast: What Researchers and Recipients Should Know about ClinicalTrials.gov | | What should researchers and recipients be aware of regarding ClinicalTrials.gov as it relates to reporting NIH grant-funded trials? Tune into this episode of the NIH All About Grants podcast to hear from Dr. Anna Fine, the Acting Director of ClinicalTrials.gov. Learn more here. |
|
| Administrative Supplements for Diversity, Re-entry and Continuity | | Many NIH recipients are aware that funds may be available for administrative supplements to address impacts to research following severe weather or other unforeseen events. Fewer recipients, however, are aware of these other administrative supplement programs to support research within the scope and timeline of a current award. Read more here. |
|
| Submitting for a UCOP funding opportunity? Remember this! | | UCOP is not an internal sponsor because the funding originates from off-campus, so all UCOP projects need to be routed via the standard KR process. For questions, please direct to your Contract & Grants Analyst. |
|
| Are you considering applying for Limited Funding Opportunities? | | In most cases, interested applicants submit a pre-proposal to the Office of Research where a committee reviews all submissions and makes a recommendation to the Vice Chancellor for Research about which proposal should go forward from UCI. Limited opportunities are advertised on fundopp.uci.edu with a link to apply. However, if you do not see a limited opportunity listed, please contact the Research Development Unit. We can relay your application plans to the UCI Office of Research so they are aware of the number of interested PIs/units on campus and, if necessary, coordinate PIs or create a review process. |
|
| Updated Grants Preparation Material Request Form | | The Grants Preparation Material Request Form (previously the Boilerplate Request Form) has been updated to include numerous NIH templates and checklists (e.g., diversity supplements, RCR, K applications, and the PEDP). Save yourself time by taking advantage of these documents. Spread the word among your colleagues about this resource and contact the Research Development Unit if you have any questions or suggestions. |
|
| What is Research Development? | Research Development encompasses strategic, proactive, and capacity-building activities designed to support individual faculty and teams of faculty in obtaining extramural research funding and also increase institutional competitiveness. The UCI School of Medicine Research Development Unit (RDU) meets individual faculty to provide information regarding research resources and assistance with grant proposals.
Do you want funding opportunities matching your research program automatically emailed to you? The RDU can also help you set up a Pivot account in minutes via Zoom and answer any questions you may have. Read more about Pivot and other Funding Search Tools. Reserve a slot here! |
|
| COVID-19 Reminders | With California’s COVID-19 state of emergency having ended on February 28, 2023, employees and students are reminded to continue to report their COVID-19 cases to Contact Tracing and Vaccine Navigation Services, which continues to investigate and contact trace cases. Free face coverings and antigen tests continue to be available on campus.
Please note that the end of the emergency does not mean the end of COVID-19, so individuals should continue to gauge their risk and take steps to protect themselves and their communities by staying up to date with vaccinations and boosters, staying home if sick, testing, washing hands and wearing masks when appropriate.
For the latest information on campus status and operational updates, please visit UCI Forward.
For UCI Health updates, please visit UCI Health's COVID-19 page on SharePoint. |
|
| Contribute to Research Insider! |
| |
|
